Intestinal lymphoma perforations as a consequence of highly effective anti-CD20 antibody therapy

Transplantation. 2002 Feb 27;73(4):669-70. doi: 10.1097/00007890-200202270-00038.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20 / immunology*
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Intestinal Neoplasms / drug therapy*
  • Intestinal Perforation / chemically induced*
  • Lymphoma, B-Cell / drug therapy*
  • Prednisolone / therapeutic use
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD20
  • Antineoplastic Agents
  • Rituximab
  • Prednisolone